期刊文献+

抗HIV巨噬细胞靶向给药系统的研究进展

Anti-HIV macrophage-targeted drug delivery systems:research advances
暂未订购
导出
摘要 巨噬细胞是人免疫缺陷病毒(HIV)的宿主,藏匿在巨噬细胞中的HIV能在适宜时机复制而导致艾滋病复发,因此,巨噬细胞可成为HIV的新传染源。目前大部分抗艾滋病药的细胞膜渗透性差、体内半衰期短,造成给药剂量大和次数频繁,并且难以在巨噬细胞内分布而清除残留HIV。因此抗HIV巨噬细胞靶向给药系统的研究很重要。本文综述了抗HIV药物的纳米给药系统及其巨噬细胞靶向作用,涉及纳米粒、脂质体、纳米混悬剂、自组装药物传递系统、纳米凝胶和纳米囊,为艾滋病治疗提供新思路。 Macrophages are the reservoir of human immunodeficiency virus(HIV).HIV hidden in the macrophages is replicated under appropriate conditions,leading to recurrence of AIDS.Macrophages are a new infection resource of HIV.Biomembrane penetration of current anti-HIV drugs is poor and the in vivo half life is short,resulting in high dose and frequent administration.Their distribution in macrophages is too little to eradicate the hidden HIV.Therefore,the development of anti-HIV macrophage-targeted delivery systems is very important.The review summarizes the nanoparticulate delivery systems of anti-HIV agents and their macrophage-targeted effects,involving nanoparticles,liposomes,nanosuspensions,self-assembled drug delivery systems,nanogels and nanocapsules,in order to provide a new strategy for the treatment of AIDS.
出处 《国际药学研究杂志》 CAS CSCD 2013年第1期39-42,共4页 Journal of International Pharmaceutical Research
基金 国家科技重大专项"重大新药创制"候选药物(2012ZX09103101-059) 国家科技重大专项"重大新药创制"综合性新药研究开发技术大平台(2012ZX09301003-001-009)
关键词 抗HIV药物 巨噬细胞 靶向 人免疫缺陷病毒 anti-HIV agents macrophage targeting human immunodeficiency virus
  • 相关文献

参考文献30

  • 1Aquaro S,Calio R,Balzarin J. Macrophages and HIV infection:therapeutical approaches toward this strategic virus reservoir[J].Antiviral Research,2002,(02):209-225.
  • 2Aquaro S,Bagnarelli P,Guenci T. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus[J].Journal of Medical Virology,2002,(04):479-488.
  • 3Pretzer E,Flasher D,Düzgunes N. Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502,an inhibitor of the viral protease[J].Antiviral Research,1997.1-15.
  • 4Sch(a)fer V,yon Briesen H,Andreesen R. Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages:a possibility for antiviral drug targeting[J].Pharmaceutical Research,1992,(04):541-546.
  • 5Bender A,Sch(a)fer V,Steffan AM. Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles[J].Research in Virology,1994,(3-4):215-220.
  • 6Bender A,von Briesen H,Kreuter J. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro[J].Antimicrobial Agents and Chemotherapy,1996,(06):1467-1471.
  • 7Shah LK,Amiji MM. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS[J].Pharmaceutical Research,2006,(11):2638-2645.
  • 8Mainardes RM,Gremi(a)o MP,Brunetti IL. Zidovudine-loaded PLA and PLA-PEG blend nanoparticles:influence of polymer type on phagocytic uptake by polymorphonuclear cells[J].Journal of Pharmaceutical Sciences,2009,(01):257-267.doi:10.1002/jps.21406.
  • 9Shegokar R,Singh KK. Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs[J].Die Pharmazie,2011,(04):264-271.
  • 10Korvasová Z,Dra(s)ar L,Ma(s)ek J. Antiviral effect of HPMPC (Cidofovir(R[J].Journal of Controlled Release,2012,(02):330-338.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部